#1 Clinical Trials Search in Europe

Carvedilol

Carvedilol is a medication that has been extensively studied in clinical trials for its potential benefits in treating various cardiovascular conditions. This article explores the use of Carvedilol in clinical research, focusing on its applications in hypertension, heart failure, and other related disorders. We’ll examine different formulations, dosages, and combinations with other drugs to better understand how Carvedilol works and its effectiveness in managing these conditions.

Table of Contents

What is Carvedilol?

Carvedilol is a medication that belongs to a class of drugs called beta-blockers. It is also known by brand names such as COREG, COREG CR, Dilatrend, and Carvida[1][2][4]. This medication is unique because it not only blocks beta receptors but also alpha receptors in the body, which gives it additional beneficial effects compared to traditional beta-blockers[5].

Medical Conditions Treated by Carvedilol

Carvedilol is used to treat several cardiovascular conditions, including:

  • Hypertension (High Blood Pressure): Carvedilol helps lower blood pressure, reducing the risk of heart attacks and strokes[2][4].
  • Chronic Stable Angina: This medication can help relieve chest pain caused by reduced blood flow to the heart[4].
  • Congestive Heart Failure: Carvedilol improves heart function and survival in patients with heart failure[4].
  • Portal Hypertension: In patients with liver cirrhosis, carvedilol can help reduce pressure in the portal vein, potentially preventing complications like variceal bleeding[1][2].

How Carvedilol Works

Carvedilol works in several ways to improve heart health and manage blood pressure:

  • Beta-blocking action: It slows down the heart rate and reduces the workload on the heart by blocking beta receptors[5].
  • Alpha-blocking action: This additional effect helps dilate blood vessels, further reducing blood pressure[5].
  • Portal pressure reduction: In liver disease, carvedilol can lower pressure in the portal vein more effectively than traditional beta-blockers, potentially preventing complications like variceal bleeding[1].

Dosage Forms and Administration

Carvedilol is available in several forms:

  • Immediate-release tablets: These are typically taken twice daily[4].
  • Controlled-release (CR) capsules: These are designed for once-daily dosing, which can be more convenient for patients[4][7].
  • Fixed-dose combinations: Some formulations combine carvedilol with other medications like lisinopril for treating hypertension[5][7].

The dosage varies depending on the condition being treated and individual patient factors. It’s crucial to take carvedilol exactly as prescribed by your healthcare provider[9][10].

Clinical Studies and Effectiveness

Numerous clinical studies have demonstrated the effectiveness of carvedilol:

  • Hypertension management: Studies have shown that carvedilol effectively lowers blood pressure, with some formulations allowing for convenient once-daily dosing[7].
  • Portal hypertension: Research suggests that carvedilol may be more effective than traditional treatments like propranolol in preventing first variceal bleeding in patients with liver cirrhosis[1][2].
  • Combination therapy: Studies have explored the use of carvedilol in combination with other treatments, such as endoscopic variceal ligation, for preventing bleeding in patients with esophageal varices[8].

Potential Side Effects and Safety

Like all medications, carvedilol can cause side effects. Common side effects may include:

  • Dizziness
  • Fatigue
  • Low blood pressure
  • Slow heart rate

It’s important to report any unusual or severe side effects to your healthcare provider. Regular monitoring of blood pressure, heart rate, and other clinical parameters is typically part of the treatment plan when taking carvedilol[4][9][10].

Carvedilol has shown a good safety profile in various studies, but as with any medication, it should be taken under the guidance of a healthcare professional. They will consider your individual health status and other medications you may be taking to ensure safe and effective treatment[9][10].

Aspect Details
Primary Conditions Studied Hypertension, Chronic Stable Angina, Congestive Heart Failure
Formulations Immediate Release (IR), Controlled Release (CR), Sustained Release (SR)
Dosages Ranging from 6.25mg to 80mg, depending on formulation and study
Key Outcome Measures Blood pressure changes, pharmacokinetic parameters (AUC, Cmax, Tmax), safety and tolerability
Study Designs Randomized, crossover, bioequivalence studies; comparison with other medications
Special Considerations Food effect studies, once-daily vs. twice-daily dosing comparisons
Combination Therapies Fixed Dose Combinations with Lisinopril, comparison with endoscopic treatments

FAQ

  • What is Carvedilol used for in clinical trials? Carvedilol is primarily studied for its use in treating hypertension (high blood pressure), chronic stable angina, and congestive heart failure. Some trials also explore its effectiveness in preventing variceal bleeding in patients with cirrhosis.
  • What are the different formulations of Carvedilol studied in clinical trials? Clinical trials have investigated various formulations of Carvedilol, including immediate-release (IR) tablets, controlled-release (CR) capsules, and sustained-release (SR) formulations. These different forms are studied to compare their effectiveness and determine the optimal dosing regimen for patients.
  • How is Carvedilol compared to other medications in clinical trials? Some trials compare Carvedilol to other medications or combinations. For example, studies have looked at Carvedilol in combination with Lisinopril (an ACE inhibitor) to see if the combination is more effective than either drug alone in treating hypertension.
  • What are some of the key outcomes measured in Carvedilol clinical trials? Clinical trials typically measure outcomes such as changes in blood pressure, heart rate, and other cardiovascular parameters. They also assess the drug's pharmacokinetics (how the body processes the drug), safety profile, and tolerability by monitoring adverse events and conducting various clinical tests.
  • Are there any special considerations for taking Carvedilol in clinical trials? Some trials investigate how food affects the absorption and effectiveness of Carvedilol. Participants may be required to take the medication under fasting or fed conditions. Additionally, trials may involve different dosing schedules (once daily or twice daily) to determine the optimal regimen for patients.

Ongoing Clinical Trials on Carvedilol

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Carvedilol for Preventing Complications in Patients with Early-Stage Cirrhosis and High Blood Pressure in the Liver

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Comparison of Carvedilol and Flecainide Treatment in Patients with Idiopathic Ventricular Arrhythmias

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Optimizing Treatment for Chronic Heart Failure with Reduced Ejection Fraction Using Nebivolol and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Czechia

  • Comparing Carvedilol and Metoprolol Succinate for Treating Heart Failure with Reduced Ejection Fraction in Patients at Heart Failure Clinics

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Bioequivalence: A measure used to assess whether different formulations of a drug have the same biological effects. In Carvedilol trials, this is often used to compare new formulations with existing ones.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. This is often measured in Carvedilol trials to understand how different formulations affect the drug's behavior in the body.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, often used in pharmacokinetic studies of Carvedilol to compare different formulations or doses.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood. This is measured in Carvedilol trials to understand how quickly the drug takes effect.
  • Half-life (t½): The time it takes for the concentration of a drug in the body to decrease by half. This is important for determining dosing schedules in Carvedilol trials.
  • Fixed Dose Combination (FDC): A combination of two or more active drugs in a single dosage form. Some Carvedilol trials study FDCs of Carvedilol with other medications like Lisinopril.
  • Crossover study: A type of clinical trial where participants receive different treatments in a specific order. This design is often used in Carvedilol trials to compare different formulations or doses.
  • Variceal Bleeding: Bleeding from enlarged veins in the esophagus or stomach, often associated with liver cirrhosis. Some trials study Carvedilol's effectiveness in preventing this condition.

References

  1. https://clinicaltrials.gov/study/NCT03720067
  2. https://clinicaltrials.gov/study/NCT01070641
  3. https://clinicaltrials.gov/study/NCT00556920
  4. https://clinicaltrials.gov/study/NCT01819870
  5. https://clinicaltrials.gov/study/NCT00537043
  6. https://clinicaltrials.gov/study/NCT00552708
  7. https://clinicaltrials.gov/study/NCT01383044
  8. https://clinicaltrials.gov/study/NCT01064180
  9. https://clinicaltrials.gov/study/NCT01064154